Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Mar-12 5:37 PM View:  | Tranzyme, Inc. (OCRX) | 14-Mar-12 | Market Purchase | 90,838 | $3.00 | $272,090.00 | 3% 3.45M to 3.54M | (95%) |
| 14-Mar-12 5:37 PM View: | Tranzyme, Inc. (OCRX) | 13-Mar-12 | Market Purchase | 159,015 | $2.96 | $470,382.00 | 5% 3.29M to 3.45M | (95%) |
| 14-Mar-12 5:37 PM View: | Tranzyme, Inc. (OCRX) | 12-Mar-12 | Market Purchase | 961,299 | $2.44 | $2,341,270.00 | 41% 2.33M to 3.29M | (94%) |
| 09-Mar-12 6:27 PM View: | Genomic Health Inc. (GHDX) | 08-Mar-12 | Market Purchase | 19,513 | $30.36 | $592,489.00 | < 1% 8.24M to 8.26M | 174% |
| 09-Mar-12 6:27 PM View: | Genomic Health Inc. (GHDX) | 07-Mar-12 | Market Purchase | 22,071 | $29.88 | $659,464.00 | < 1% 8.21M to 8.24M | 179% |
| 05-Mar-12 6:28 PM View: | Genomic Health Inc. (GHDX) | 05-Mar-12 | Market Purchase | 155,014 | $30.01 | $4,651,480.00 | 2% 8.06M to 8.21M | 178% |
| 05-Mar-12 6:28 PM View: | Genomic Health Inc. (GHDX) | 02-Mar-12 | Market Purchase | 91,459 | $29.52 | $2,699,920.00 | 1% 7.97M to 8.06M | 182% |
| 05-Mar-12 6:28 PM View: | Genomic Health Inc. (GHDX) | 01-Mar-12 | Market Purchase | 15,288 | $29.47 | $450,543.00 | < 1% 7.95M to 7.97M | 183% |
| 29-Feb-12 5:41 PM View: | Genomic Health Inc. (GHDX) | 29-Feb-12 | Market Purchase | 156,902 | $29.06 | $4,559,270.00 | 2% 7.8M to 7.95M | 187% |
| 29-Feb-12 5:41 PM View: | Genomic Health Inc. (GHDX) | 28-Feb-12 | Market Purchase | 51,248 | $29.11 | $1,491,750.00 | < 1% 7.74M to 7.8M | 186% |
| 29-Feb-12 5:41 PM View: | Genomic Health Inc. (GHDX) | 27-Feb-12 | Market Purchase | 36,881 | $29.03 | $1,070,680.00 | < 1% 7.71M to 7.74M | 187% |
| 23-Feb-12 6:11 PM View: | Genomic Health Inc. (GHDX) | 23-Feb-12 | Market Purchase | 62,098 | $28.12 | $1,746,430.00 | < 1% 7.64M to 7.71M | 196% |
| 23-Feb-12 6:11 PM View: | Genomic Health Inc. (GHDX) | 22-Feb-12 | Market Purchase | 5,511 | $27.98 | $154,204.00 | < 1% 7.64M to 7.64M | 198% |
| 23-Feb-12 6:11 PM View: | Genomic Health Inc. (GHDX) | 21-Feb-12 | Market Purchase | 46,909 | $27.98 | $1,312,370.00 | < 1% 7.59M to 7.64M | 198% |
| 16-Feb-12 6:57 PM View: | Genomic Health Inc. (GHDX) | 16-Feb-12 | Market Purchase | 184,980 | $29.73 | $5,499,500.00 | 2% 7.41M to 7.59M | 180% |
| 16-Feb-12 6:57 PM View: | Genomic Health Inc. (GHDX) | 15-Feb-12 | Market Purchase | 32,125 | $28.88 | $927,680.00 | < 1% 7.38M to 7.41M | 189% |
| 16-Feb-12 6:57 PM View: | Genomic Health Inc. (GHDX) | 14-Feb-12 | Market Purchase | 55,804 | $28.44 | $1,586,900.00 | < 1% 7.32M to 7.38M | 193% |
| 10-Feb-12 9:34 PM View: | Genomic Health Inc. (GHDX) | 10-Feb-12 | Market Purchase | 159,832 | $26.59 | $4,249,930.00 | 2% 7.16M to 7.32M | 213% |
| 10-Feb-12 9:34 PM View: | Genomic Health Inc. (GHDX) | 09-Feb-12 | Market Purchase | 55,994 | $26.32 | $1,473,630.00 | < 1% 7.1M to 7.16M | 217% |
| 10-Feb-12 9:34 PM View: | Genomic Health Inc. (GHDX) | 08-Feb-12 | Market Purchase | 202,089 | $26.20 | $5,294,560.00 | 3% 6.9M to 7.1M | 218% |
| 03-Feb-12 5:52 PM View: | Ardea Biosciences, Inc. (RDEA) | 01-Feb-12 | Market Purchase | 876,828 | $17.00 | $14,906,100.00 | 22% 4.05M to 4.92M | 11% |
| 26-Jan-12 6:12 PM View: | Pharmacyclics Inc. (PCYC) | 26-Jan-12 | Market Purchase | 243,790 | $17.93 | $4,371,850.00 | 3% 8.33M to 8.57M | 1357% |
| 26-Jan-12 6:12 PM View: | Pharmacyclics Inc. (PCYC) | 25-Jan-12 | Market Purchase | 125,551 | $18.53 | $2,326,620.00 | 2% 8.21M to 8.33M | 1310% |
| 26-Jan-12 6:12 PM View: | Pharmacyclics Inc. (PCYC) | 24-Jan-12 | Market Purchase | 131,311 | $17.95 | $2,357,590.00 | 2% 8.07M to 8.21M | 1355% |
| 23-Jan-12 8:40 PM View: | Pharmacyclics Inc. (PCYC) | 23-Jan-12 | Market Purchase | 162,215 | $16.87 | $2,737,010.00 | 2% 7.91M to 8.07M | 1448% |
| 23-Jan-12 8:40 PM View: | Pharmacyclics Inc. (PCYC) | 20-Jan-12 | Market Purchase | 248,166 | $16.42 | $4,073,980.00 | 3% 7.64M to 7.89M | 1492% |
| 23-Jan-12 8:40 PM View: | Pharmacyclics Inc. (PCYC) | 20-Jan-12 | Exercise (in-the money or at-the-money) | 24,900 | $15.00 | $373,500.00 | < 1% 7.89M to 7.91M | 1642% |
| 23-Jan-12 8:40 PM View: | Pharmacyclics Inc. (PCYC) | 19-Jan-12 | Market Purchase | 34,857 | $16.05 | $559,459.00 | < 1% 7.6M to 7.64M | 1528% |
| 17-Jan-12 8:43 PM View: | Incyte Corp (INCY) | 13-Jan-12 | Market Purchase | 217,511 | $16.53 | $3,595,230.00 | 2% 12.21M to 12.43M | 428% |
| 17-Jan-12 8:43 PM View: | Incyte Corp (INCY) | 12-Jan-12 | Market Purchase | 325,728 | $16.26 | $5,297,470.00 | 3% 11.89M to 12.21M | 437% |
| 09-Jan-12 7:01 PM View: | Trimeris Inc. (GEVA) | 05-Jan-12 | Grant | 1,077,220 | $25.18 | $27,124,500.00 | 27% 4.0M to 5.08M | 837% |
| 04-Jan-12 7:25 PM View: | Seattle Genetics Inc. (SGEN) | 30-Dec-11 | Exercise (in-the money or at-the-money) | 355,143 | $6.25 | $2,219,640.00 | 2% 14.78M to 15.13M | |
| 03-Jan-12 6:02 PM View: | Adolor Corp. (ADLR) | 19-Dec-11 | Disposition (change in control) | 6,669,340 | $4.25 | $28,344,700.00 | (100%) 6.67M to 0 | |
| 16-Dec-11 4:27 PM View: | ViroPharma Inc. (VPHM) | 14-Dec-11 | Market Purchase | 291,706 | $27.29 | $7,960,160.00 | 3% 9.55M to 9.84M | 82% |
| 12-Dec-11 5:23 PM View: | Incyte Corp (INCY) | 09-Dec-11 | Market Purchase | 181,201 | $13.26 | $2,402,410.00 | 2% 11.71M to 11.89M | 559% |
| 12-Dec-11 5:23 PM View: | Incyte Corp (INCY) | 08-Dec-11 | Market Purchase | 222,320 | $13.46 | $2,992,190.00 | 2% 11.48M to 11.71M | 549% |
| 07-Dec-11 5:57 PM View: | Incyte Corp (INCY) | 07-Dec-11 | Market Purchase | 144,903 | $13.22 | $1,915,210.00 | 1% 11.34M to 11.48M | 561% |
| 07-Dec-11 5:57 PM View: | Incyte Corp (INCY) | 06-Dec-11 | Market Purchase | 338,406 | $13.53 | $4,578,060.00 | 3% 11.0M to 11.34M | 545% |
| 05-Dec-11 6:16 PM View: | Genomic Health Inc. (GHDX) | 05-Dec-11 | Market Purchase | 20,456 | $28.45 | $582,072.00 | < 1% 6.88M to 6.9M | 193% |
| 07-Dec-11 5:57 PM View: | Incyte Corp (INCY) | 05-Dec-11 | Market Purchase | 1,071,820 | $13.89 | $14,883,200.00 | 11% 9.93M to 11.0M | 529% |
| 06-Dec-11 6:09 PM View: | Pharmacyclics Inc. (PCYC) | 02-Dec-11 | Market Purchase | 88,197 | $15.42 | $1,359,610.00 | 1% 7.52M to 7.6M | 1595% |
| 05-Dec-11 6:16 PM View: | Genomic Health Inc. (GHDX) | 02-Dec-11 | Market Purchase | 97,295 | $28.05 | $2,729,230.00 | 1% 6.78M to 6.88M | 197% |
| 01-Dec-11 4:31 PM View: | Incyte Corp (INCY) | 01-Dec-11 | Market Purchase | 828,622 | $14.12 | $11,698,400.00 | 9% 9.1M to 9.93M | 519% |
| 30-Nov-11 6:19 PM View: | Pharmacyclics Inc. (PCYC) | 30-Nov-11 | Market Purchase | 65,002 | $14.92 | $969,966.00 | < 1% 7.45M to 7.52M | 1651% |
| 01-Dec-11 4:31 PM View: | Incyte Corp (INCY) | 30-Nov-11 | Market Purchase | 507,911 | $13.44 | $6,826,900.00 | 6% 8.59M to 9.1M | 550% |
| 30-Nov-11 6:19 PM View: | Pharmacyclics Inc. (PCYC) | 29-Nov-11 | Market Purchase | 162,271 | $14.18 | $2,300,340.00 | 2% 7.29M to 7.45M | 1743% |
| 01-Dec-11 4:31 PM View: | Incyte Corp (INCY) | 29-Nov-11 | Market Purchase | 1,069,650 | $12.21 | $13,063,000.00 | 14% 7.52M to 8.59M | 615% |
| 30-Nov-11 6:19 PM View: | Pharmacyclics Inc. (PCYC) | 28-Nov-11 | Market Purchase | 150,007 | $13.34 | $2,001,150.00 | 2% 7.14M to 7.29M | 1858% |
| 23-Nov-11 5:04 PM View: | Pharmacyclics Inc. (PCYC) | 23-Nov-11 | Market Purchase | 93,194 | $12.76 | $1,189,160.00 | 1% 7.04M to 7.14M | 1948% |
| 23-Nov-11 4:59 PM View: | Genomic Health Inc. (GHDX) | 23-Nov-11 | Market Purchase | 67,427 | $25.83 | $1,741,720.00 | 1% 6.72M to 6.78M | 223% |